Posted Sep. 29, 2011 at 7:44 a.m.

Premium Lock BioDelivery Sciences drug candidate fails in trial

Published: 2011-09-29 07:44:24
Updated: 2011-09-29 07:44:24


The chronic pain reliver didn't perform better than a placebo in a Phase 3 clinical trial, but the Raleigh company isn'r giving up....

Read More
Read More

Copyright 2017 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders